Once-Weekly ART Showed Similar Efficacy for HIV as Daily ART
(MedPage Today) -- DENVER -- A once-weekly oral antiretroviral therapy (ART) regimen of the investigational drug islatravir, a nucleoside reverse transcriptase translocation inhibitor, with lenacapavir (Sunlenca) showed similar efficacy to daily...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news
More News: Infectious Diseases | Translocation